Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Guillem Argiles
Initial Experience With the Bispecific Anti-Cea Anti-Cd3 Antibody and Its Expected Impact on Future Treatment for Patients With Colorectal Cancer
ESMO Open
Cancer Research
Oncology
Health-Related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses
Clinical Colorectal Cancer
Oncology
Gastroenterology
Related publications
Phase I Study of Anti-Cd3 X Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients
Prostate Cancer
Cancer Research
Oncology
Urology
An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors
Science Translational Medicine
Medicine
Development of PF-06671008, a Highly Potent Anti-P-Cadherin/Anti-Cd3 Bispecific DART Molecule With Extended Half-Life for the Treatment of Cancer
Antibodies
Drug Discovery
Allergy
Immunology
Efficient Elimination of Chronic Lymphocytic Leukaemia B Cells by Autologous T Cells With a Bispecific Anti-Cd19/Anti-Cd3 Single-Chain Antibody Construct
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Novel Asymmetrical Anti-Her2/Cd3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Clinical Activity of Regn1979, an Anti-Cd20 X Anti-Cd3 Bispecific Antibody (Ab) in Patients (Pts) With (W/) Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Development and Clinical Application of Anti-Her2 Monoclonal and Bispecific Antibodies for Cancer Treatment
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Study of Enhancement of Anti-Tumor Effect by Lectin on LAK Cells Induced by rIL-2 With Anti-Cd3 Antibody.
Japanese Journal of Oral & Maxillofacial Surgery